Oncology.TV

@UC6DdH8ovsjVeZkRgON5PCpw - 2.1K subscribers

This Oncology.TV YouTube Channel offers you the exclusive opportunity to view high definition uploads of the video content featured on Oncology.TV. To see more videos, free continuing education programs, the latest oncology news headlines and other oncology-related information be sure to visit www.oncology.tv and register today!

Home Videos Live Playlists

120CML12 Oncology.TV

32 views - 8 years ago

120CML04 Oncology.TV

35 views - 8 years ago

120CML09 Oncology.TV

28 views - 8 years ago

120CML01 Oncology.TV

33 views - 8 years ago

120CML03 Oncology.TV

115 views - 8 years ago

120CML10 Oncology.TV

20 views - 8 years ago

120CML14 Oncology.TV

44 views - 8 years ago

120CML02 Oncology.TV

58 views - 8 years ago

120CML08 Oncology.TV

64 views - 8 years ago

120CML06 Oncology.TV

38 views - 8 years ago

120CML07 Oncology.TV

31 views - 8 years ago

120CML11 Oncology.TV

31 views - 8 years ago

120CML05 Oncology.TV

25 views - 8 years ago

120CML13 Oncology.TV

47 views - 8 years ago

AML On The Go - Minimal Residual Disease Eradication with Epigenetic

AML On The Go - Minimal Residual Disease Eradication with Epigenetic Oncology.TV

224 views - 8 years ago

AMl On The Go - Should MRD Monitoring Debate Pro

AMl On The Go - Should MRD Monitoring Debate Pro Oncology.TV

83 views - 8 years ago

AML On The Go - Debate: Should MRD Monitoring in AML - Pro

AML On The Go - Debate: Should MRD Monitoring in AML - Pro Oncology.TV

117 views - 8 years ago

AML On The Go: Targeted Therapy of IDH1/IDH2 Mutated AML

AML On The Go: Targeted Therapy of IDH1/IDH2 Mutated AML Oncology.TV

428 views - 8 years ago

AMl On The Go - Gemtuzumab Ozogamicin in AML

AMl On The Go - Gemtuzumab Ozogamicin in AML Oncology.TV

1K views - 8 years ago

AML On The Go - Selective Inhibition of FLT3 by Gilteritinib

AML On The Go - Selective Inhibition of FLT3 by Gilteritinib Oncology.TV

691 views - 8 years ago

AML On The Go - Differentiation Syndrome Associated with Enasidenib

AML On The Go - Differentiation Syndrome Associated with Enasidenib Oncology.TV

544 views - 8 years ago

AML On The Go: Debate: Should MRD Monitoring in AML - Con - Part 2 of 2

AML On The Go: Debate: Should MRD Monitoring in AML - Con - Part 2 of 2 Oncology.TV

25 views - 8 years ago

AML On The Go - Debate: Should MRD Monitoring in AML...Con - Part 1 of 2

AML On The Go - Debate: Should MRD Monitoring in AML...Con - Part 1 of 2 Oncology.TV

57 views - 8 years ago

AML On The Go - The Next Questions - Module 1 of 2

AML On The Go - The Next Questions - Module 1 of 2 Oncology.TV

62 views - 8 years ago

AML On The Go - Characteristics and Outcomes of Older Patients with Secondary AML

AML On The Go - Characteristics and Outcomes of Older Patients with Secondary AML Oncology.TV

57 views - 8 years ago

AML On The Go - The Next Questions - Module 2 of 2

AML On The Go - The Next Questions - Module 2 of 2 Oncology.TV

29 views - 8 years ago

AML On The Go - News & Views - Cabozantinib is Well Tolerated in AML and Effectively Inhibits

AML On The Go - News & Views - Cabozantinib is Well Tolerated in AML and Effectively Inhibits Oncology.TV

40 views - 8 years ago

AML On The Go - AML in the Older Patient: Science or Craft? - Module 1 of 2

AML On The Go - AML in the Older Patient: Science or Craft? - Module 1 of 2 Oncology.TV

30 views - 8 years ago

AML On The Go - PD-1/PD-L2 Expression is Upregulated by Epigenetic

AML On The Go - PD-1/PD-L2 Expression is Upregulated by Epigenetic Oncology.TV

80 views - 8 years ago

AML On The Go - Management of the Older Adult WIth AML - Part 2 of 2

AML On The Go - Management of the Older Adult WIth AML - Part 2 of 2 Oncology.TV

29 views - 8 years ago

AML On The Go - Phase IB/III Study of Nivolumab in Combination with

AML On The Go - Phase IB/III Study of Nivolumab in Combination with Oncology.TV

50 views - 8 years ago

News & Views - New Chemotherapeutic Approaches in AML - Part 2 of 2

News & Views - New Chemotherapeutic Approaches in AML - Part 2 of 2 Oncology.TV

44 views - 8 years ago

AML On The Go - Application of NGS In Newly Diagnosed AML

AML On The Go - Application of NGS In Newly Diagnosed AML Oncology.TV

161 views - 8 years ago

AML On The Go - Immune Checkpoint based approaches in AML- Module 1 of 2

AML On The Go - Immune Checkpoint based approaches in AML- Module 1 of 2 Oncology.TV

257 views - 8 years ago

AML On The Go - Emerging Immunotherapies in AML

AML On The Go - Emerging Immunotherapies in AML Oncology.TV

133 views - 8 years ago

AML On The Go - Impact of Patient Reported Symptoms on Physical

AML On The Go - Impact of Patient Reported Symptoms on Physical Oncology.TV

43 views - 8 years ago

AML On The Go - SWOG S1203: A Randomized Phase III Study of Standard

AML On The Go - SWOG S1203: A Randomized Phase III Study of Standard Oncology.TV

479 views - 8 years ago

AML On The Go - Perspectives and Future Directions in AML Therapy and Research

AML On The Go - Perspectives and Future Directions in AML Therapy and Research Oncology.TV

32 views - 8 years ago

AML On The Go - AML: State of the Art and the Summer of 2017 Module 1 of 2

AML On The Go - AML: State of the Art and the Summer of 2017 Module 1 of 2 Oncology.TV

47 views - 8 years ago

AML On The Go - AML: State of the Art and the Summer of 2017 Module 2 of 2

AML On The Go - AML: State of the Art and the Summer of 2017 Module 2 of 2 Oncology.TV

47 views - 8 years ago

AML On The Go - Application of NGS In Newly Diagnosed AML

AML On The Go - Application of NGS In Newly Diagnosed AML Oncology.TV

76 views - 8 years ago

AML On The Go - Highlights in AML

AML On The Go - Highlights in AML Oncology.TV

80 views - 8 years ago

AML On The Go - Molecular Determinants of Response in Acute Myeloid Leukemia - Module 1 of 2

AML On The Go - Molecular Determinants of Response in Acute Myeloid Leukemia - Module 1 of 2 Oncology.TV

223 views - 8 years ago

AML On The Go - Molecular Determinants of Response in Acute Myeloid Leukemia - Module 2 of 2

AML On The Go - Molecular Determinants of Response in Acute Myeloid Leukemia - Module 2 of 2 Oncology.TV

82 views - 8 years ago

AML On The Go - BCL-2 Inhibition in Acute Myeloid Leukemia

AML On The Go - BCL-2 Inhibition in Acute Myeloid Leukemia Oncology.TV

406 views - 8 years ago

AML On The Go - New Chemotherapeutic Approaches in AML - Module 1 of 2

AML On The Go - New Chemotherapeutic Approaches in AML - Module 1 of 2 Oncology.TV

116 views - 8 years ago

Perspectives and Future Directions for CML

Perspectives and Future Directions for CML Oncology.TV

56 views - 9 years ago

CLL - Then and Now

CLL - Then and Now Oncology.TV

137 views - 9 years ago

Perspectives and Future Directions for Hem Onc Research

Perspectives and Future Directions for Hem Onc Research Oncology.TV

61 views - 9 years ago

Perspectives in Lymphoma

Perspectives in Lymphoma Oncology.TV

30 views - 9 years ago

Perspectives and Future Directions for ALL

Perspectives and Future Directions for ALL Oncology.TV

50 views - 9 years ago

Perspectives and Future Directions in AML Therapy and Research

Perspectives and Future Directions in AML Therapy and Research Oncology.TV

12 views - 9 years ago

Perspectives and Future Directions for MM

Perspectives and Future Directions for MM Oncology.TV

189 views - 9 years ago

Animal Models of MPN - What Do They Teach Us?

Animal Models of MPN - What Do They Teach Us? Oncology.TV

35 views - 9 years ago

Novel Agents and Combination Strategies in MF

Novel Agents and Combination Strategies in MF Oncology.TV

32 views - 9 years ago

Perspectives and Future Directions in ET and PV

Perspectives and Future Directions in ET and PV Oncology.TV

25 views - 9 years ago

What Does This Patient Have: ET, PV or Masked PV?

What Does This Patient Have: ET, PV or Masked PV? Oncology.TV

752 views - 9 years ago

Biology and Targeting of Eosinophilic MPNs

Biology and Targeting of Eosinophilic MPNs Oncology.TV

180 views - 9 years ago

Path To A Cure for Myeloma

Path To A Cure for Myeloma Oncology.TV

137 views - 9 years ago

Novel Agents for HL

Novel Agents for HL Oncology.TV

37 views - 9 years ago